Quest Laboratories Ltd IPO
Open Demat Account
Quest Laboratories Ltd IPO Details
Details
| Total Shares Offered | Offer to Public | Retail Max (Shares) | Pre Issue Promoters Holding | Exchange | Issue size |
|---|---|---|---|---|---|
| ₹ 44.5 L | TBA | ₹ 14.99 L | ₹ 105.74 L | NSE | ₹ 43.16 Cr |
| IPO Open Date | Close Date | Lot Size | Min Investment | Issue Type | Listing Date |
| 15 May, 24 | 17 May, 24 | 1200 | ₹ 1,11,600 | Book Building - SME | 23 May, 24 |
Quest Laboratories Ltd IPO Dates
Details
| Sector | Type |
|---|---|
| Sector | Pharmaceuticals - Indian - Formulations |
| Sub Sector | NA |
| Issue Type | Book Building - SME |
Subscription Status
*Values are in Lakhs
| Investor Type | Subscription Times | Shares Offered* | Shares Bid* |
|---|---|---|---|
| QIB | 23.01x | 2067600 | 47571600 |
| NII | 184.45x | 655200 | 120852000 |
| Retail | 57.63x | 1498800 | 86370000 |
| Employee | 0x | 0 | 0 |
| Total | 57.26x | 4449600 | 254793600 |
Subscription Status
Investor Type
QIB
NII
Retail
Employee
Total
*Values are in Lakhs
Quest Laboratories Ltd Financial Status
Income Statement
Balance Sheet
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Revenue from operations | 15.01 | 7.53 | 6.23 |
| EBITDA | 15.58 | 8.08 | 6.69 |
| PAT | 10.09 | 5.04 | 4.11 |
| Total Assets | 41.64 | 33.98 | 26.85 |
| Share Capital | 11.94 | 1.08 | 1.08 |
| Total Borrowings | 7.04 | 6.84 | 5.24 |
| Operating Activities (Net Cash) | 10.66 | 5.59 | 4.57 |
| Investing Activities (Net Cash) | 0.09 | 0.09 | 0.09 |
| Financing Activities (Net Cash) | 7.04 | 6.84 | 5.24 |
| Net Cashflow | 0.14 | 0.12 | 1.57 |
Particulars (in Rs. Crores)
Revenue from operations
EBITDA
PAT
Total Assets
Share Capital
Total Borrowings
Operating Activities (Net Cash)
Investing Activities (Net Cash)
Financing Activities (Net Cash)
Net Cashflow
About Quest Laboratories Ltd
Quest Laboratories Limited was originally incorporated under the name Quest Laboratories Private Limited under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated June 01, 1998, issued by the Registrar of Companies Madhya Pradesh, Gwalior. Subsequently, the status of the Company was changed to public limited and the name of the Company was changed to Quest Laboratories Limited vide Special Resolution passed by the Shareholders at the Extra Ordinary General Meeting of the Company held on January 11, 2024. The fresh certificate of incorporation consequent to conversion was issued on January 23, 2024, by Assistant Registrar of Companies/ Deputy Registrar of Companies/ Registrar of Companies, Centralised Processing Centre. The Corporate Identification Number of the Company is U24232MP1998PLC012850.
India's pharmaceutical industry leads globally, renowned for affordable generic drugs and vaccines. With a 9.43% CAGR over nine years, it ranks third in production volume. Diverse segments include generics, OTC meds, bulk drugs, vaccines, biosimilars, and biologics. Notably, India houses the most USFDA-compliant manufacturing facilities and 500 API producers, capturing 8% of the global API market. This industry's growth reflects its adaptability and quality standards, ensuring accessible healthcare solutions worldwide.
Quest Laboratories Limited is engaged in the business of manufacturing of pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. These formulations fall under the trademark Quest Laboratories Limited. The company produces a variety of products, comprising ethical drugs, generic drugs, and overthe-counter drugs (OTC). These products are available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. This comprehensive approach allows the Company to address a wide range of medical needs and preferences among patients.
Peer Comparison:
- Beta Drugs Ltd
- Alpa Laboratories Ltd
- Zenith Drugs Ltd
Quest Laboratories Ltd IPO Key Points
Strengths
- Multi-product capability.
- Revenue from Government institutions.
- Product Portfolio.
- Research and Development.
- Quality assurance.
Risk
- The company has certain outstanding litigation against it, an adverse outcome of which may adversely affect its business, reputation and results of operations.
- Any manufacturing or quality control problems may disrupt its business operations, damage the company reputation for high quality production and expose it to potential litigation or other liabilities, which would negatively impact its business, prospects, cash flows, results of operations and financial condition.
- The Company is reliant on the demand from the pharmaceutical industry for a significant portion of its revenue. Any downturn in the pharmaceutical industry or an inability to increase or effectively manage its sales could have an adverse impact on the Company's business and results of operations.
Strategy
- Expansion and upgradation of its manufacturing facility.
- Expand its Geographical Presence.
- Widen its product portfolio.
- Continue to improve operating efficiencies through technology enhancements.
- Multi-product capability.
- Revenue from Government institutions.
- Product Portfolio.
- Research and Development.
- Quality assurance.
How To Apply for Quest Laboratories Ltd IPO Online?
Step 1:
Log in to the BlinkX stock market app and click ‘IPO’ in the Xplore section.
Step 2:
From the list of open IPOs, select the IPO you want to invest.
Step 3:
Go through the IPO details like lot size, price band, about the company, etc.
Step 4:
Click ‘Apply IPO’ to apply and enter the number of lots and bidding price along with your UPI ID.
Step 5:
Confirm your bid and accept the payment mandate sent to your UPI App for completing the IPO application.
